Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
about
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.Pathology in prostate research: optimizing the pathological data.Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis.Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.Prognostic factors in prostate cancer.Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy.Should Gleason 6 be labeled as cancer?Serum prostate-specific antigen value adjusted for non-cancerous prostate tissue volume in patients undergoing radical prostatectomy: a new predictor of biochemical recurrence in localized or locally advanced prostate cancer.The prognostic significance of percentage of tumour involvement according to disease risk group in men treated with radical prostatectomy.Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume.Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.The association between tumour density and prostate cancer recurrence following radical prostatectomy.Analysis of preoperative detection for apex prostate cancer by transrectal biopsy.Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer.Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?Calculated tumor volume is an independent predictor of biochemical recurrence in patients who underwent retropubic radical prostatectomy.Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy.Biochemical recurrence risk factors in surgically treated high and very high-risk prostate tumors.Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens.Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer.Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
P2860
Q33651064-9C577894-8019-43FA-B11A-740C3D48054FQ33909029-B44D3539-5496-4327-94EC-A33A6D277FA9Q33983603-CC31DFB1-F94F-40EF-91C0-9BACFC9B18F0Q34013761-103E85BC-6EDF-4682-8ECD-BBB562982DB9Q34682069-FFB132A7-57F2-4523-A665-0EF3DD4CA982Q36018610-C1777420-EC2E-4C5A-904D-48B9CEC0A435Q36104473-0AF04E57-1E06-4AED-B076-6C0BAB1BBEE3Q36931932-B9B88D4F-BE01-46D6-B20D-287786264A04Q37084339-01EBBC58-3268-4DDC-9C68-4055FFE274B8Q37085214-15832678-4640-4D30-9AC4-86B10C9103A9Q37366891-E137C0E0-300C-4D55-831F-C580B7B425B9Q37785484-DBBDA0A8-84C5-4B1F-8DF5-87E2030E55E7Q38067446-CDFF9FBC-7420-48E2-B48E-930E118F5547Q39717982-7E9822F7-AD0D-45B1-A3CF-CEFCFBC4DD05Q41206632-04DEB6E5-C850-43ED-9EB9-4D419304C767Q41520637-039AE1EE-AD75-4C6F-BEA4-8118B4F9C615Q41897986-DAE8B555-8A9E-48A4-897F-CDD2849A5B4EQ41906136-FDE900CB-B3B0-4BD7-8D4A-71ADC5B09DADQ42399332-7EACDE5E-D02E-45FA-9686-45033F3CE86DQ43177826-E8C87BD6-E810-4215-8A7F-CB34E061BCE9Q43425184-A7389B44-01B0-4762-BEEA-5108307DFF97Q44762389-C41FA2BA-05C7-4FC0-A50F-5EB8CE30A31FQ48674916-D752DA7B-2D77-463B-A416-7829A91041FEQ51026823-491F066A-529B-44D1-81AC-C4E8D53A288AQ51074429-C8D99C42-873B-4A34-8EA1-E15E86BAEAF1Q51721144-BCB38A04-2F47-4522-90B2-6C68706F945EQ51743377-94E2F4A8-B1D7-4A8E-9A54-28D9DF9382C2Q53248380-C11D3D33-02AF-47F2-9934-85AED8F2A5DA
P2860
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@en
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@nl
type
label
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@en
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@nl
prefLabel
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@en
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@nl
P2093
P1476
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
@en
P2093
Kevin M Slawin
Makoto Ohori
Peter T Scardino
Thomas M Wheeler
P304
P356
10.1097/01.JU.0000130481.04082.1A
P407
P50
P577
2004-08-01T00:00:00Z